DexCom (DXCM) Tops Q4 EPS by 3c ; Offers Guidance
Tweet
Share
E-mailGet Alerts DXCM Hot Sheet
Price: $67.35 --0%
Revenue Growth %: +11.2%
Financial Fact:
Interest expense: -200K
Today's EPS Names:
CRMT, FOMI, FLES, More
Revenue Growth %: +11.2%
Financial Fact:
Interest expense: -200K
Today's EPS Names:
CRMT, FOMI, FLES, More
Join SI Premium – FREE
DexCom (NASDAQ: DXCM) reported Q4 EPS of $0.68, $0.03 better than the analyst estimate of $0.65. Revenue for the quarter came in at $1.26 billion versus the consensus estimate of $1.24 billion.
GUIDANCE:
DexCom sees FY2026 revenue of $5.16-5.25 billion, versus the consensus of $5.23 billion.
For earnings history and earnings-related data on DexCom (DXCM) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- FactSet (FDS) Tops Q3 EPS by 8c ; Offers Guidance
- FrontView REIT raises 2026 net investment guidance to $110M
- QXO (QXO) Reiterated at Buy by Benchmark as Estimates Move Higher
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
